Rhonda Farnum sold $227K of Theravance Biopharma stock
By AlphaYouPublished Form 4
Farnum Rhonda
Reporting filer
Rhonda Farnum reported selling 13,314 shares of Theravance Biopharma, Inc. for about $227K ($17.03 a share on average). Form 4 filed Sep 17, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Sep 17, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Farnum Rhonda | 2026-09-15 | S | Sale | 3329 | 17.0341 | 223,461 | 2 days | Filed terms
|
| Ordinary Shares | Farnum Rhonda | 2026-09-15 | S | Sale | 3328 | 17.0343 | 220,133 | 2 days | Filed terms
|
| Ordinary Shares | Farnum Rhonda | 2026-09-15 | S | Sale | 6657 | 17.0342 | 213,476 | 2 days | Filed terms
|
Ordinary Shares
- Owner
- Farnum Rhonda
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 3329
- Price
- 17.0341
- Following holdings
- 223,461
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 3329
- transaction Price Per Share: 17.0341
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 223461
- direct Or Indirect Ownership: D
- nature Of Ownership:
Ordinary Shares
- Owner
- Farnum Rhonda
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 3328
- Price
- 17.0343
- Following holdings
- 220,133
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 3328
- transaction Price Per Share: 17.0343
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 220133
- direct Or Indirect Ownership: D
- nature Of Ownership:
Ordinary Shares
- Owner
- Farnum Rhonda
- Date
- 2026-09-15
- Code
- S
- Action
- Sale
- Quantity
- 6657
- Price
- 17.0342
- Following holdings
- 213,476
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-09-15
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 6657
- transaction Price Per Share: 17.0342
- id: F1
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 213476
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Farnum Rhonda: SVP, COMM & MEDICAL AFFAIRS.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was executed in multiple trades at prices from $17.02 to $17.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Original sources
Prepared automatically from public filing data. Report a correction.